06/29/2017 - 4:21pm

The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.

06/26/2017 - 3:48pm

Rituxan Hycela contains hyaluronidase human, an enzyme that helps with the subcutaneous delivery of Rituxan's active ingredient, rituximab, allowing for faster administration compared with intravenous Rituxan.

06/23/2017 - 1:10pm

US Bioservices has been around for more than 20 years, offering support and dispensing services for patients who need specialty medications.

06/19/2017 - 1:48pm

Testing will be available at more than 220 participating Walgreens stores in 130 cities.

06/13/2017 - 1:00pm
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). 
06/12/2017 - 2:36pm

The latest report on generics cost savings, compiled by the QuintilesIMS Institute on behalf of the Association for Accessible Medicines, highlights the key role generics play in healthcare cost savings. 

06/09/2017 - 12:12pm

Jeff Park was OptumRx’s COO from July 2015 to July 2016 following the company’s merger with Catamaran, where Park had been EVP operations since March 2014.

06/09/2017 - 11:05am

According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.

06/06/2017 - 4:25pm

The Cincinnati Enquirer included Diplomat Specialty Infusion Group as one of its Top Workplaces 2017.